Taproot Medical Technologies LLC
Bothell, WA
- UEI
- UG6LYQZZKX33
- CAGE
- 7VAM4
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 22122 20th Ave SE #150, Bothell, WA 98021, USA
- Website
- taprootmedical.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Acatechol, Inc. | Pasadena, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Isurtec | Saint Paul, MN | 541713 Research and Development in Nanotechnology |
| Madison Scientific, Inc. | Madison, WI | — |
| Aleo BME Inc. | State College, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Shape Memory Therapeutics | San Jose, CA | 339112 Surgical and Medical Instrument Manufacturing |
About the company
Taproot Medical Technologies LLC is a company that specializes in advanced biopolymers and medical device manufacturing, focused on developing innovative products to address urgent healthcare challenges. One of their key products is a state-of-the-art ventricular catheter to address issues with shunt failures in the treatment of hydrocephalus.
Through several federal grant awards from agencies like the Department of the Army Medical Command and the National Science Foundation, Taproot Medical Technologies has developed innovative zwitterion-treated ventricular catheters to prevent shunt failures in hydrocephalus treatment. They received a $2,995,903 project grant in 2022 from the Military Medical Research and Development program to fund this ventricular catheter development over two years. Prior awards include a $290,512 grant in 2020 from the same Army program for initial development of the zwitterionic polymer coating, and a $1,282,979 grant from the NSF in 2019 for an injectable, enzyme-degradable hydrogel formulation as a tissue filler. Taproot's work through these grants has focused on cutting-edge biomedical solutions like anti-biofouling catheter coatings and advanced polymers for medical applications, supporting the development of new products to improve health outcomes.
Quick answers
Is Taproot Medical Technologies LLC registered in SAM.gov?
Taproot Medical Technologies LLC's SAM.gov registration expired on June 3, 2026.
What is Taproot Medical Technologies LLC's most recent federal award?
Taproot Medical Technologies LLC's most recent federal grant award is An innovative zwitterion-treated ventricular catheter to prevent shunt failure in hydrocephalus treatment (W81XWH2210405), from Defense Health Agency, on May 15, 2022.
On GovTribe
See Taproot Medical Technologies LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors